Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.
In this episode of CURE Talks Cancer, we talk with retired NHL referee Kerry Fraser about his MPN diagnosis, his advocacy work, and how he uses the lessons he learned on the ice and works with his winning team to conquer each day.
Information about myeloproliferative neoplasms – or MPNs – is hard to come by. But the MPN Research Foundation’s myMPN Patient Registry aims to change that. Learn more about it in this week's episode of the CURE Talks Cancer podcast.